
Savola Group Company
2050.SRSAUConsumer Defensive● Active
$29.50
+$0.50(+1.72%)
Market Cap$8.8B
P/E Ratio—
52W High$30.2
52W Low$20.45
Savola Group Company(2050.SR)· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · 2050.SR · 截至 2026-06-15
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.99B | $3.02B | $1.97B | $1.48B | $1.40B |
| Net Receivables | $2.59B | $2.86B | $1.75B | $2.43B | $2.08B |
| Inventory | $4.82B | $4.17B | $4.25B | $4.64B | $3.60B |
| Total Current Assets | $8.87B | $10.79B | $9.55B | $9.45B | $7.94B |
| PP&E Net | $8.90B | $8.50B | $9.09B | $9.06B | $9.19B |
| Goodwill | $0.70B | $0.70B | $0.88B | $0.97B | $0.98B |
| Intangible Assets | $0.71B | $0.70B | $0.80B | $0.82B | $0.88B |
| Total Assets | $20.48B | $21.39B | $29.96B | $29.56B | $28.55B |
| Liabilities | |||||
| Short-Term Debt | $1.89B | $3.37B | $3.94B | $4.06B | $3.32B |
| Accounts Payable | $3.92B | $3.68B | $3.51B | $3.89B | $2.91B |
| Total Current Liabilities | $9.54B | $11.59B | $11.33B | $11.64B | $9.46B |
| Long-Term Debt | $0.00B | $0.03B | $4.70B | $4.08B | $5.14B |
| Total Liabilities | $14.01B | $15.82B | $20.43B | $20.25B | $19.45B |
| Stockholders Equity | |||||
| Retained Earnings | $3.70B | $2.81B | $4.14B | $3.55B | $2.84B |
| Total Stockholders Equity | $5.52B | $4.62B | $8.45B | $8.25B | $8.08B |
| Total Liab & Equity(computed) | $19.53B | $20.44B | $28.88B | $28.50B | $27.53B |
| Debt Summary | |||||
| Total Debt | $5.84B | $7.00B | $12.11B | $11.87B | $12.32B |
| Net Debt | $4.93B | $4.76B | $10.90B | $10.43B | $10.94B |
数据来源:Financial Modeling Prep · 最后更新:2026-06-15 · SAR · B
深入了解Savola Group Company
关于Savola Group Company(2050.SR)资产负债表
Savola Group Company总资产$20.48B,现金及短期投资$0.99B,总负债$14.01B,总债务$5.84B,股东权益$5.52B。
常见问题
2050.SR · 4 问Savola Group Company总债务$5.84B,净债务$4.93B。
2050.SR total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15